Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors

Maria F. Paz, Sonia Avila, Mario F. Fraga, Marina Pollan, Gabriel Capella, Miquel Angel Peinado, Montserrat Sanchez-Cespedes, James G. Herman, Manel Esteller

Research output: Contribution to journalArticle

Abstract

Aberrant DNA methylation is recognized as being a common feature of human neoplasia. CpG island hypermethylation and global genomic hypomethylation occur simultaneously in the cancer cell. However, very little is known about the interindividual inherited susceptibility to these epigenetic processes. To address this matter, we have genotyped in 233 cancer patients (with colorectal, breast, or lung tumors), four germ-line variants in three key genes involved in the metabolism of the methyl group, methylene-tetrahydrofolate reductase, methionine synthase, and cystathionine β-synthase, and analyzed their association with DNA methylation parameters. The epigenetic features analyzed were the 5-methylcytosine content in the genome of the tumors and their normal counterparts, and the presence of CpG island hypermethylation of tumor suppressor genes (p16INK4α, P14ARF, hMLH1, MGMT, APC, LKB1, DAPK, GSTP1, BRCA1, RARβ2, CDH1, and RASSF1). Two positive associations were found. First, carriers of genotypes containing the methylene-tetrahydrofolate reductase 677T allele show constitutive low levels of 5-methylcytosine in their genomes (P = 0.002), and tumors in these patients do not achieve severe degrees of global hypomethylation (P = 0.047). Second, tumors occurring in homozygous carriers of the methionine synthase 2756G allele show a lower number of hypermethylated CpG islands of tumor suppressor genes (P = 0.029). The existence of these associations may provide another example of the interplay between genetic and epigenetic factors in the cancer cell.

Original languageEnglish (US)
Pages (from-to)4519-4524
Number of pages6
JournalCancer Research
Volume62
Issue number15
StatePublished - Aug 1 2002

Fingerprint

DNA Methylation
Germ Cells
CpG Islands
Genes
Neoplasms
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
5-Methylcytosine
Methylenetetrahydrofolate Reductase (NADPH2)
Tumor Suppressor Genes
Epigenomics
Alleles
Genetic Epigenesis
Cystathionine
Genome
Breast
Genotype
Lung

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Paz, M. F., Avila, S., Fraga, M. F., Pollan, M., Capella, G., Peinado, M. A., ... Esteller, M. (2002). Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Research, 62(15), 4519-4524.

Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. / Paz, Maria F.; Avila, Sonia; Fraga, Mario F.; Pollan, Marina; Capella, Gabriel; Peinado, Miquel Angel; Sanchez-Cespedes, Montserrat; Herman, James G.; Esteller, Manel.

In: Cancer Research, Vol. 62, No. 15, 01.08.2002, p. 4519-4524.

Research output: Contribution to journalArticle

Paz, MF, Avila, S, Fraga, MF, Pollan, M, Capella, G, Peinado, MA, Sanchez-Cespedes, M, Herman, JG & Esteller, M 2002, 'Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors', Cancer Research, vol. 62, no. 15, pp. 4519-4524.
Paz MF, Avila S, Fraga MF, Pollan M, Capella G, Peinado MA et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Research. 2002 Aug 1;62(15):4519-4524.
Paz, Maria F. ; Avila, Sonia ; Fraga, Mario F. ; Pollan, Marina ; Capella, Gabriel ; Peinado, Miquel Angel ; Sanchez-Cespedes, Montserrat ; Herman, James G. ; Esteller, Manel. / Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. In: Cancer Research. 2002 ; Vol. 62, No. 15. pp. 4519-4524.
@article{3c91eb3915024370bd0a04ebb5c21a28,
title = "Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors",
abstract = "Aberrant DNA methylation is recognized as being a common feature of human neoplasia. CpG island hypermethylation and global genomic hypomethylation occur simultaneously in the cancer cell. However, very little is known about the interindividual inherited susceptibility to these epigenetic processes. To address this matter, we have genotyped in 233 cancer patients (with colorectal, breast, or lung tumors), four germ-line variants in three key genes involved in the metabolism of the methyl group, methylene-tetrahydrofolate reductase, methionine synthase, and cystathionine β-synthase, and analyzed their association with DNA methylation parameters. The epigenetic features analyzed were the 5-methylcytosine content in the genome of the tumors and their normal counterparts, and the presence of CpG island hypermethylation of tumor suppressor genes (p16INK4α, P14ARF, hMLH1, MGMT, APC, LKB1, DAPK, GSTP1, BRCA1, RARβ2, CDH1, and RASSF1). Two positive associations were found. First, carriers of genotypes containing the methylene-tetrahydrofolate reductase 677T allele show constitutive low levels of 5-methylcytosine in their genomes (P = 0.002), and tumors in these patients do not achieve severe degrees of global hypomethylation (P = 0.047). Second, tumors occurring in homozygous carriers of the methionine synthase 2756G allele show a lower number of hypermethylated CpG islands of tumor suppressor genes (P = 0.029). The existence of these associations may provide another example of the interplay between genetic and epigenetic factors in the cancer cell.",
author = "Paz, {Maria F.} and Sonia Avila and Fraga, {Mario F.} and Marina Pollan and Gabriel Capella and Peinado, {Miquel Angel} and Montserrat Sanchez-Cespedes and Herman, {James G.} and Manel Esteller",
year = "2002",
month = "8",
day = "1",
language = "English (US)",
volume = "62",
pages = "4519--4524",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors

AU - Paz, Maria F.

AU - Avila, Sonia

AU - Fraga, Mario F.

AU - Pollan, Marina

AU - Capella, Gabriel

AU - Peinado, Miquel Angel

AU - Sanchez-Cespedes, Montserrat

AU - Herman, James G.

AU - Esteller, Manel

PY - 2002/8/1

Y1 - 2002/8/1

N2 - Aberrant DNA methylation is recognized as being a common feature of human neoplasia. CpG island hypermethylation and global genomic hypomethylation occur simultaneously in the cancer cell. However, very little is known about the interindividual inherited susceptibility to these epigenetic processes. To address this matter, we have genotyped in 233 cancer patients (with colorectal, breast, or lung tumors), four germ-line variants in three key genes involved in the metabolism of the methyl group, methylene-tetrahydrofolate reductase, methionine synthase, and cystathionine β-synthase, and analyzed their association with DNA methylation parameters. The epigenetic features analyzed were the 5-methylcytosine content in the genome of the tumors and their normal counterparts, and the presence of CpG island hypermethylation of tumor suppressor genes (p16INK4α, P14ARF, hMLH1, MGMT, APC, LKB1, DAPK, GSTP1, BRCA1, RARβ2, CDH1, and RASSF1). Two positive associations were found. First, carriers of genotypes containing the methylene-tetrahydrofolate reductase 677T allele show constitutive low levels of 5-methylcytosine in their genomes (P = 0.002), and tumors in these patients do not achieve severe degrees of global hypomethylation (P = 0.047). Second, tumors occurring in homozygous carriers of the methionine synthase 2756G allele show a lower number of hypermethylated CpG islands of tumor suppressor genes (P = 0.029). The existence of these associations may provide another example of the interplay between genetic and epigenetic factors in the cancer cell.

AB - Aberrant DNA methylation is recognized as being a common feature of human neoplasia. CpG island hypermethylation and global genomic hypomethylation occur simultaneously in the cancer cell. However, very little is known about the interindividual inherited susceptibility to these epigenetic processes. To address this matter, we have genotyped in 233 cancer patients (with colorectal, breast, or lung tumors), four germ-line variants in three key genes involved in the metabolism of the methyl group, methylene-tetrahydrofolate reductase, methionine synthase, and cystathionine β-synthase, and analyzed their association with DNA methylation parameters. The epigenetic features analyzed were the 5-methylcytosine content in the genome of the tumors and their normal counterparts, and the presence of CpG island hypermethylation of tumor suppressor genes (p16INK4α, P14ARF, hMLH1, MGMT, APC, LKB1, DAPK, GSTP1, BRCA1, RARβ2, CDH1, and RASSF1). Two positive associations were found. First, carriers of genotypes containing the methylene-tetrahydrofolate reductase 677T allele show constitutive low levels of 5-methylcytosine in their genomes (P = 0.002), and tumors in these patients do not achieve severe degrees of global hypomethylation (P = 0.047). Second, tumors occurring in homozygous carriers of the methionine synthase 2756G allele show a lower number of hypermethylated CpG islands of tumor suppressor genes (P = 0.029). The existence of these associations may provide another example of the interplay between genetic and epigenetic factors in the cancer cell.

UR - http://www.scopus.com/inward/record.url?scp=0036682379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036682379&partnerID=8YFLogxK

M3 - Article

C2 - 12154064

AN - SCOPUS:0036682379

VL - 62

SP - 4519

EP - 4524

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 15

ER -